Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN [Journal of Crohn's and Colitis, 630 (2018)]

2018-04-27

doi:10.1093/ecco-jcc/jjx172

Journal of Crohn's and Colitis , Volume 12 - Issue 5 p. 630- 630

In the original article, author Carsten Posovszky's surname was incorrectly spelt. This has now been corrected.

Additional Metadata
Persistent URL	doi.org/10.1093/ecco-jcc/jjx172, hdl.handle.net/1765/106312
Journal	Journal of Crohn's and Colitis
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ledder, O. (Oren), Assa, A. (Amit), Levine, A., Escher, J., de Ridder, L., Ruemmele, F., … Turner, D. (2018). Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN [Journal of Crohn's and Colitis, 630 (2018)]. Journal of Crohn's and Colitis, 12(5), 630–630. doi:10.1093/ecco-jcc/jjx172

Publication